Medtronic Announces Early Site Release of New Radial Artery Access Portfolio Following First-in-Patient Procedure Medical Device Investing
Eversea Confirms Launch of the World's First Organic Omega-3 DHA Supplement Across USA Biotech Investing
Medtronic Recognized as One of Fortune's 2021 World's Most Admired Companies Medical Device Investing
Seelos Therapeutics to Participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health Conference February 3-4 Psychedelics Investing
Algernon Pharmaceuticals Launches Stroke Treatment Clinical Research Program with Psychedelic Drug DMT "The Spirit Molecule" Biotech Investing
Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange Psychedelics Investing
Prevent Blindness and Bausch + Lomb to Launch Year-Long Video Series to Raise Awareness of Age-Related Macular Degeneration Medical Device Investing
Bristol Myers Squibb Application for Zeposia® for the Treatment of Ulcerative Colitis Accepted for Filing with Priority Review by U.S. Food and Drug Administration Biotech Investing
Merck Receives Positive EU CHMP Opinion for Expanded Approval of KEYTRUDA® in Certain Patients With Relapsed or Refractory Classical Hodgkin Lymphoma Pharmaceutical Investing
